PT  - JOURNAL ARTICLE
AU  - Owaidah, Tarek M.
TI  - Donor lymphocyte infusion. An adaptive cellular immunotherapy for treatment of hematological malignancies
DP  - 2003 Feb 01
TA  - Saudi Medical Journal
PG  - 138--141
VI  - 24
IP  - 2
4099  - http://smj.org.sa/content/24/2/138.short
4100  - http://smj.org.sa/content/24/2/138.full
SO  - Saudi Med J2003 Feb 01; 24
AB  - The application of immunotherapy in the treatment of hematological malignancies is relatively new. Donor lymphocyte infusion (DLI) is a form of adaptive cellular therapy where the transfer of cells from immunocompetent donor to patient with cancer who relapsed after bone marrow transplantation results in destruction of the malignant cells. Hereby, we review the concepts, mechanisms, and results of the application of DLI in treatment of some hematological malignancies.